Manuja Nishtha, Daiya Varun, Malali Suprit, Kadu Ajinkya, Kumar Sunil, Acharya Sourya
Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND.
Cureus. 2024 May 7;16(5):e59813. doi: 10.7759/cureus.59813. eCollection 2024 May.
The leading cause of isolated thrombocytopenia in asymptomatic individuals is immune thrombocytopenia (ITP). It is an autoimmune disease characterized by decreased platelet counts caused by the immune system's destruction of platelets. Sometimes, autoimmune thyroid diseases and ITP can coexist, which could cause an aggravated immune system response. When thyroid autoimmune diseases are present, treating ITP may become challenging. Treatment of the underlying thyroid disease in such individuals results in a significant improvement in platelet count, along with remission of the disease. It enhances the response to traditional ITP therapy. In this case report, we present a case of a 40-year-old female who was treated for ITP along with hypothyroidism, resulting in a considerable improvement in platelet count and a remission of the condition.
无症状个体孤立性血小板减少症的主要原因是免疫性血小板减少症（ITP）。它是一种自身免疫性疾病，其特征是免疫系统破坏血小板导致血小板计数减少。有时，自身免疫性甲状腺疾病和ITP可能同时存在，这可能会导致免疫系统反应加剧。当存在甲状腺自身免疫性疾病时，治疗ITP可能会变得具有挑战性。治疗此类个体潜在的甲状腺疾病会使血小板计数显著改善，同时疾病缓解。这增强了对传统ITP治疗的反应。在本病例报告中，我们呈现了一名40岁女性的病例，她同时接受了ITP和甲状腺功能减退的治疗，血小板计数得到了显著改善，病情缓解。
